Direct answer
What did this PTR report?
Kathy Manning reported a sale (partial) involving CME Group Inc. - Class A Common Stock (CME) (source ticker CME) on July 2, 2024. The source reports $1,001 - $15,000.
Open official PDF page 4 ↗U.S. House PTR · North Carolina District 6
Kathy Manning
Sale (partial) · CME Group Inc. - Class A Common Stock (CME)
July 2, 2024$1,001 - $15,000Document 20025679
SALE (PARTIAL)
Verified source fields
Transaction record
- Filer
- Kathy Manning
- House district
- NC06
- Asset
- CME Group Inc. - Class A Common Stock (CME)
- Official asset type
- ST · Stocks (including ADRs)
- Source ticker
- CME
- Transaction code
- S (partial) · Sale (partial)
- Transaction date
- July 2, 2024
- Notification date
- August 14, 2024
- Reported value
- $1,001 - $15,000
- Owner field
- Spouse
- Filing status
- New
- PDF location
- Page 4 · row 2
Source context
Notes printed with this row
- Subholding of
- Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2
Interpretation boundary
A reported transaction is not a verdict.
THIS PAGE CAN SAY
The filer, asset text, codes, dates, amount label, filing status, and notes above appear in the fingerprinted official PTR at the cited page.
THIS PAGE CANNOT SAY
A disclosed transaction is not evidence of wrongdoing, material nonpublic information, intent, profit, loss, investment performance, a current holding, net worth, or a conflict of interest. Most dollar values are disclosure ranges, not exact transaction amounts. Some amended official rows contain an exact dollar value; amount_is_exact distinguishes those rows. Numeric bounds are derived only from an unambiguous source value and the original label is always retained.
Same official filing
Other verified rows in document 20025679
PurchaseSeven Bridges Multi-Strategy Fund Ltd.Aug 1, 2024 · $100,001 - $250,000 →Sale (partial)Seven Bridges Long/Short Equity Fund SeriesJul 30, 2024 · $500,001 - $1,000,000 →Sale (partial)Seven Bridges Long/Short Equity Fund Ltd.Jul 26, 2024 · $100,001 - $250,000 →PurchaseAbbott Laboratories Common Stock (ABT)Jul 2, 2024 · $1,001 - $15,000 →PurchaseAbbott Laboratories Common Stock (ABT)Jul 2, 2024 · $1,001 - $15,000 →PurchaseAbbVie Inc. Common Stock (ABBV)Jul 2, 2024 · $1,001 - $15,000 →Sale (partial)Accenture plc Class A Ordinary Shares (ACN)Jul 2, 2024 · $1,001 - $15,000 →Sale (partial)Accenture plc Class A Ordinary Shares (ACN)Jul 2, 2024 · $1,001 - $15,000 →
Same source name and district
Other recent disclosed transactions
This is an exact source-name and district match, not a durable person-identifier join.
Sale (partial)Seven Bridges Long/Short Equity Fund Ltd.Jan 1, 2025 · $15,001 - $50,000 →Sale (partial)Seven Bridges Long/Short Equity Fund SeriesJan 1, 2025 · $50,001 - $100,000 →Sale (partial)Seven Bridges Long/Short Equity Fund SeriesJan 1, 2025 · $15,001 - $50,000 →SaleSeven Bridges Emerging Markets Fund SeriesDec 31, 2024 · $500,001 - $1,000,000 →SaleSeven Bridges Emerging Markets Fund SeriesDec 31, 2024 · $100,001 - $250,000 →Sale (partial)Seven Bridges Multi-Strategy Fund Ltd.Dec 31, 2024 · $100,001 - $250,000 →SaleSeven Bridges Strategic Equity Fund SeriesDec 31, 2024 · $1,000,001 - $5,000,000 →SaleSeven Bridges Strategic Equity Fund SeriesDec 31, 2024 · $250,001 - $500,000 →